School of Medicine
Sunitinib is a chemotherapeutic agent that has been approved for renal cell carcinoma and gastrointestinal stromal tumors resistant to imatinib. It is usually well tolerated and severe gastrointestinal side effects are rare. There are very few reports of sunitinib causing severe esophagitis, and only one of them was previously reported as exfoliative esophagitis. We describe a case of severe sunitinib-induced exfoliative esophagitis that resulted in overt gastrointestinal bleed.
Digital Commons Citation
Gayam, Swapna MD and Anumandla, Ashwini MD, "A Rare Case of Sunitinib-Induced Exfoliative Esophagitis" (2016). Faculty & Staff Scholarship. 2014.
Gayam, S., & Anumandla, A. (2016). A Rare Case of Sunitinib-Induced Exfoliative Esophagitis. ACG Case Reports Journal, 3(1), e155. https://doi.org/10.14309/crj.2016.128